Vascular endothelial growth factor is increased in patients with preeclampsia (Q36888688)

16 August 2017

title

Vascular endothelial growth factor is increased in patients with preeclampsia (English)

1 reference

16 August 2017

0 references

0 references

M J Kupferminc

1

1 reference

16 August 2017

Y Daniel

2

1 reference

16 August 2017

T Englender

3

1 reference

16 August 2017

A Baram

4

1 reference

16 August 2017

A Many

5

1 reference

16 August 2017

A J Jaffa

6

1 reference

16 August 2017

I Gull

7

1 reference

16 August 2017

J B Lessing

8

1 reference

16 August 2017

language of work or name

1 reference

1 October 1997

1 reference

American Journal of Reproductive Immunology

16 August 2017

published in

1 reference

16 August 2017

volume

38

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

302-306

1 reference

Sera from preeclamptic women specifically activate human umbilical vein endothelial cells in vitro: morphological and biochemical evidence

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Preeclampsia: an endothelial cell disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Preeclampsia is associated with a serum factor cytotoxic to human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Molecular and biological properties of the vascular endothelial growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Vascular endothelial growth factor is a secreted angiogenic mitogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

The role of vascular endothelial growth factor in pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Vascular endothelial growth factor, a potent and selective angiogenic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Endothelial receptor tyrosine kinases involved in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Immunohistochemical localization of vascular endothelial growth factor in the human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Vascular permeability factor (VPF, VEGF) in tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Hyperuricemia and xanthine oxidase in preeclampsia, revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0897.1997.TB00519.X

10.1111/J.1600-0897.1997.TB00519.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference